tradingkey.logo
搜索

硕腾

ZTS
添加自选
122.380USD
+3.350+2.81%
收盘 04/17, 16:00美东报价延迟15分钟
52.00B总市值
20.30市盈率 TTM

硕腾

122.380
+3.350+2.81%

关于 硕腾 公司

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).

硕腾简介

公司代码ZTS
公司名称Zoetis Inc
上市日期Feb 01, 2013
CEOPeck (Kristin C)
员工数量13800
证券类型Ordinary Share
年结日Feb 01
公司地址10 Sylvan Way
城市PARSIPPANY
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编07054
电话19738227000
网址https://www.zoetis.com/
公司代码ZTS
上市日期Feb 01, 2013
CEOPeck (Kristin C)

硕腾公司高管

名称
名称/职务
职务
持股
持股变动
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
105.90K
+0.02%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
18.17K
--
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
16.26K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.71K
+9.15%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
3.92K
--
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.73K
+0.72%
Mr. Keith Sarbaugh
Mr. Keith Sarbaugh
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
3.35K
+30.01%
Dr. Robert J. (Rob) Polzer, Ph.D.
Dr. Robert J. (Rob) Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
1.96K
-216.45%
Mr. Nicholas (Nick) Ashton
Mr. Nicholas (Nick) Ashton
Executive Vice President, President - Global Manufacturing and Supply
Executive Vice President, President - Global Manufacturing and Supply
1.82K
+39.96%
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
105.90K
+0.02%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
18.17K
--
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
16.26K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.71K
+9.15%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
3.92K
--

收入明细

单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Parasiticides
2.34B
24.73%
Vaccines
1.96B
20.69%
Dermatology
1.75B
18.53%
Anti-infectives
1.04B
10.94%
Pain and sedation
840.00M
8.87%
其他
1.54B
16.24%
地区USD
名称
营收
占比
United States
5.10B
53.84%
Other emerging markets
913.00M
9.64%
Other Developed
641.00M
6.77%
Brazil
393.00M
4.15%
Australia
329.00M
3.48%
其他
2.09B
22.12%
业务
地区
业务USD
名称
营收
占比
Parasiticides
2.34B
24.73%
Vaccines
1.96B
20.69%
Dermatology
1.75B
18.53%
Anti-infectives
1.04B
10.94%
Pain and sedation
840.00M
8.87%
其他
1.54B
16.24%

股东统计

更新时间: 2月19日 周四
更新时间: 2月19日 周四
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
11.31%
BlackRock Institutional Trust Company, N.A.
5.66%
State Street Investment Management (US)
4.71%
State Farm Insurance Companies
4.01%
Wellington Management Company, LLP
2.71%
其他
71.60%
持股股东
持股股东
占比
The Vanguard Group, Inc.
11.31%
BlackRock Institutional Trust Company, N.A.
5.66%
State Street Investment Management (US)
4.71%
State Farm Insurance Companies
4.01%
Wellington Management Company, LLP
2.71%
其他
71.60%
股东类型
持股股东
占比
Investment Advisor
51.02%
Investment Advisor/Hedge Fund
33.49%
Research Firm
4.21%
Insurance Company
4.10%
Pension Fund
2.98%
Bank and Trust
2.63%
Hedge Fund
1.45%
Sovereign Wealth Fund
1.45%
Individual Investor
0.08%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
2795
428.61M
99.51%
--
2026Q1
3338
427.05M
101.16%
-14.43M
2025Q4
3335
436.13M
98.96%
-14.08M
2025Q3
3275
435.62M
98.29%
-1.39M
2025Q2
3277
434.35M
98.00%
-1.58M
2025Q1
3284
432.42M
97.12%
-4.21M
2024Q4
3199
430.60M
96.14%
-9.58M
2024Q3
3090
434.14M
95.81%
-13.19M
2024Q2
3062
437.75M
95.94%
-9.33M
2024Q1
3060
439.45M
96.16%
-2.63M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
47.57M
11.27%
+5.47M
+12.99%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
23.78M
5.63%
+982.47K
+4.31%
Dec 31, 2025
State Street Investment Management (US)
19.80M
4.69%
+149.38K
+0.76%
Dec 31, 2025
State Farm Insurance Companies
16.88M
4%
+9.70K
+0.06%
Dec 31, 2025
Wellington Management Company, LLP
11.39M
2.7%
+2.85M
+33.41%
Dec 31, 2025
Geode Capital Management, L.L.C.
11.33M
2.68%
+189.24K
+1.70%
Dec 31, 2025
Morgan Stanley Investment Management Ltd. (UK)
6.65M
1.58%
-827.17K
-11.06%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
5.84M
1.38%
+646.40K
+12.45%
Dec 31, 2025
Polen Capital Management, LLC
5.56M
1.32%
-1.95M
-26.00%
Dec 31, 2025
Nordea Funds Oy
4.93M
1.17%
+2.18M
+79.17%
Dec 31, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
ProShares Pet Care ETF
9.4%
VanEck Pharmaceutical ETF
9.02%
VanEck Agribusiness ETF
7.81%
iShares U.S. Pharmaceuticals ETF
4.26%
Honeytree US Equity ETF
3.86%
First Trust NASDAQ Pharmaceuticals ETF
3.58%
Polen Capital Global Growth ETF
3.35%
State Street SPDR S&P Pharmaceuticals ETF
2.51%
AAM Sawgrass US Large Cap Quality Growth ETF
2.47%
Themes US R&D Champions ETF
1.96%
查看更多
ProShares Pet Care ETF
占比9.4%
VanEck Pharmaceutical ETF
占比9.02%
VanEck Agribusiness ETF
占比7.81%
iShares U.S. Pharmaceuticals ETF
占比4.26%
Honeytree US Equity ETF
占比3.86%
First Trust NASDAQ Pharmaceuticals ETF
占比3.58%
Polen Capital Global Growth ETF
占比3.35%
State Street SPDR S&P Pharmaceuticals ETF
占比2.51%
AAM Sawgrass US Large Cap Quality Growth ETF
占比2.47%
Themes US R&D Champions ETF
占比1.96%

分红派息

近5年累计派现 2.56B 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 05, 2026
ZTS.NB Interim Cash Dividend of gross USD 0.53 paid on Jun 02, 2026 going ex on Apr 20, 2026
Apr 20, 2026
Jun 02, 2026
Apr 20, 2026
Dec 11, 2025
ZTS.NB Interim Cash Dividend of gross USD 0.53 paid on Mar 03, 2026 going ex on Jan 20, 2026
Jan 20, 2026
Mar 03, 2026
Jan 20, 2026
Oct 09, 2025
ZTS.NB Final Cash Dividend of gross USD 0.5 paid on Dec 02, 2025 going ex on Oct 31, 2025
Oct 31, 2025
Dec 02, 2025
Oct 31, 2025
May 21, 2025
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Sep 03, 2025 going ex on Jul 18, 2025
Jul 18, 2025
Sep 03, 2025
Jul 18, 2025
Feb 06, 2025
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Jun 03, 2025 going ex on Apr 21, 2025
Apr 21, 2025
Jun 03, 2025
Apr 21, 2025
Dec 12, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Mar 04, 2025 going ex on Jan 21, 2025
Jan 21, 2025
Mar 04, 2025
Jan 21, 2025
Oct 10, 2024
ZTS.NB Final Cash Dividend of gross USD 0.432 paid on Dec 03, 2024 going ex on Oct 31, 2024
Oct 31, 2024
Dec 03, 2024
Oct 31, 2024
May 22, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Sep 04, 2024 going ex on Jul 18, 2024
Jul 18, 2024
Sep 04, 2024
Jul 18, 2024
Feb 06, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Jun 04, 2024 going ex on Apr 18, 2024
Apr 19, 2024
Jun 04, 2024
Apr 18, 2024
Dec 07, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Mar 01, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Mar 01, 2024
Jan 18, 2024
查看更多

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI